Brent L. Saunders, Director: ARS Pharmaceuticals SPRY Planned sale · Filed 25/05/20

Trade details

Type: Planned sale notice
Stock: ARS Pharmaceuticals SPRY
Person: Brent L. SaundersDirector
Planned sale date: 25/05/20
Filed: 25/05/20

0.1% of shares outstanding to be sold

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/04/20~25/06/19

Brent L. Saunders's recent trades

Brent L. SaundersCEO and Chairman
BuyBausch & Lomb
Buy
Bausch & Lomb
BLCO
$252K
14,700 sh
$252K
Filed 03/10
Traded 03/06
Brent L. SaundersCEO and Chairman
BuyBausch & Lomb
Buy
Bausch & Lomb
BLCO
$248.2K
22,000 sh
$248.2K
Filed 25/05/27
Traded 25/05/22
Brent L. SaundersDirector
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$1.7M
120,000 sh
$1.7M
Filed 25/05/22
Traded 25/05/20
Brent L. SaundersDirector
BuySkinHealth Systems
Buy
SkinHealth Systems
SKIN
$43.7K
40,450 sh
$43.7K
Filed 24/08/13
Traded 24/08/12
Brent L. SaundersCEO and Chairman
BuyBausch & Lomb
Buy
Bausch & Lomb
BLCO
$505K
32,250 sh
$505K
Filed 24/08/07
Traded 24/08/05